<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Medicine (Baltimore)</journal-id><journal-id journal-id-type="iso-abbrev">Medicine (Baltimore)</journal-id><journal-id journal-id-type="publisher-id">MD</journal-id><journal-title-group><journal-title>Medicine</journal-title></journal-title-group><issn pub-type="ppub">0025-7974</issn><issn pub-type="epub">1536-5964</issn><publisher><publisher-name>Lippincott Williams &#x00026; Wilkins</publisher-name><publisher-loc>Hagerstown, MD</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40388745</article-id><article-id pub-id-type="pmc">PMC12091597</article-id>
<article-id pub-id-type="publisher-id">MD-D-25-02937</article-id><article-id pub-id-type="art-access-id">00026</article-id><article-id pub-id-type="doi">10.1097/MD.0000000000042457</article-id><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" article-version-type="Version of Record">3</article-version><article-categories><subj-group subj-group-type="heading"><subject>5300</subject></subj-group><subj-group><subject>Research Article</subject><subject>Observational Study</subject></subj-group></article-categories><title-group><article-title>Using eQTL Mendelian randomization and transcriptomic analysis to identify the relationship between ion channel genes and intracranial aneurysmal subarachnoid hemorrhage</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Jing</given-names></name><degrees>MD</degrees><email>wangjing20516@163.com</email><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Bowang</given-names></name><degrees>MD</degrees><email>13405378545@163.com</email><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Meng</surname><given-names>Qiang</given-names></name><degrees>MD</degrees><email>mengqiang1985@126.com</email><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Qu</surname><given-names>Feng</given-names></name><degrees>MD</degrees><email>rmyyzzeq@163.com</email><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0006-0963-0086</contrib-id><name><surname>Ma</surname><given-names>Zhen</given-names></name><degrees>MD</degrees><xref rid="aff1" ref-type="aff">a</xref><xref rid="c1" ref-type="corresp">*</xref></contrib><aff id="aff1"><label>a</label> Department of Intensive Care Unit, Jining No. 1 People&#x02019;s Hospital, Shandong, China.</aff></contrib-group><author-notes><corresp id="c1"><label>*</label>Correspondence: Zhen Ma, Department of Intensive Care Unit, Jining No. 1 People&#x02019;s Hospital, Shandong, China (e-mail: <email xlink:href="18264763805@163.com">18264763805@163.com</email>).</corresp></author-notes><pub-date pub-type="collection"><day>16</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>16</day><month>5</month><year>2025</year></pub-date><volume>104</volume><issue>20</issue><elocation-id>e42457</elocation-id><history><date date-type="received"><day>11</day><month>3</month><year>2025</year></date><date date-type="received"><day>27</day><month>4</month><year>2025</year></date><date date-type="accepted"><day>28</day><month>4</month><year>2025</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2025 the Author(s). Published by Wolters Kluwer Health, Inc.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License 4.0 (CCBY)</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="medi-104-e42457.pdf"/><abstract><p>Aneurysmal subarachnoid hemorrhage (aSAH) is a complex condition associated with high disability and mortality rates, leading to poor clinical outcomes. Previous observational studies have suggested a link between ion channel genes and aSAH, but the causal relationship remains uncertain. This study utilized Mendelian randomization (MR) to explore the causal association between ion channel genes and aSAH, employing 5 MR methods: inverse variance weighted (IVW), MR-Egger, maximum likelihood, weighted median, and weighted mode. If results from these methods are inconclusive, IVW will be prioritized as the primary outcome. Additionally, MR-Egger, MR-PRESSO, and Cochrane <italic toggle="yes">Q</italic> tests were conducted to assess heterogeneity and pleiotropy. The stability of MR findings was evaluated using the leave-one-out approach; Bonferroni correction tested the strength of the causal relationship between exposure and outcome. The MR analysis revealed that CACNA2D3 was positively correlated with aSAH (OR 1.245; 95% confidence intervals [CI] 1.008&#x02013;1.537; <italic toggle="yes">P</italic>&#x02005;=&#x02005;.042), while ANO6 showed a negative correlation (OR 0.728; 95% CI 0.533&#x02013;0.993; <italic toggle="yes">P</italic>&#x02005;=&#x02005;.045). Our findings indicate that increased expression of CACNA2D3 promotes aSAH whereas elevated levels of ANO6 inhibit it. Transcriptome data from intracranial aneurysm samples confirmed significant differential expression of CACNA2D3 and ANO6 between ruptured and unruptured groups. CACNA2D3 being higher in ruptured cases while ANO6 was more expressed in unruptured ones. Furthermore, GeneMANIA analysis along with functional enrichment provided insights into risk factors for aSAH. Through MR analysis, we established a causal link between ion channel genes and aSAH, which helps to better understand the pathogenesis of aSAH and provide new therapeutic targets.</p></abstract><kwd-group><kwd>aneurysmal subarachnoid hemorrhage</kwd><kwd>expression quantitative trait loci</kwd><kwd>genome-wide association analysis</kwd><kwd>ion channel genes</kwd><kwd>Mendelian randomization</kwd><kwd>transcriptome</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>OPEN-ACCESS</meta-name><meta-value>TRUE</meta-value></custom-meta><custom-meta><meta-name>SDC</meta-name><meta-value>T</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>
1. Introduction</title><p>Intracranial aneurysm (IA) is characterized by the localized pathological dilation of the intracranial artery wall, resulting in a pouch-like protrusion, with an estimated prevalence of approximately 3.2% in the general population.<sup>[<xref rid="R1" ref-type="bibr">1</xref>]</sup> Approximately 80% of subarachnoid hemorrhage cases are attributed to IA rupture, referred to as aneurysmal subarachnoid hemorrhage (aSAH).<sup>[<xref rid="R2" ref-type="bibr">2</xref>]</sup> A systematic review and meta-analysis encompassing 75 studies involving 8176 patients revealed that the crude global incidence rate of aSAH declined from 10.2 per 100,000 individuals annually in 1980 to 6.1 per 100,000 individuals annually in 2010; however, significant variations were observed based on region, age, and sex.<sup>[<xref rid="R3" ref-type="bibr">3</xref>]</sup> Despite this reduction in incidence rates, aSAH continues to be a catastrophic cerebrovascular condition with mortality rates reaching up to 50% and morbidity rates as high as 70%.<sup>[<xref rid="R4" ref-type="bibr">4</xref>,<xref rid="R5" ref-type="bibr">5</xref>]</sup> In comparison to ischemic stroke patients, those affected by aSAH tend to be approximately 20 years younger on average; this demographic difference contributes to prolonged chronic phases and disability durations while necessitating greater allocation of social resources.<sup>[<xref rid="R6" ref-type="bibr">6</xref>]</sup> Although advancements in medical technology and innovations such as neurointerventional techniques have markedly improved treatment outcomes for IAs, the mortality and disability rates associated with aSAH remain alarmingly elevated. Therefore, it is imperative to further investigate and reassess the pathophysiological mechanisms underlying aSAH along with its potential contributing factors.</p><p>Ion channels are manifested in virtually all vascular cell types, encompassing endothelial cells, smooth muscle cells, and fibroblasts.<sup>[<xref rid="R7" ref-type="bibr">7</xref>&#x02013;<xref rid="R9" ref-type="bibr">9</xref>]</sup> These ion channels exert pivotal functions in a plethora of physiological regulatory processes, such as membrane potential maintenance, signal transduction, hemodynamics, and vascular contractility.<sup>[<xref rid="R10" ref-type="bibr">10</xref>,<xref rid="R11" ref-type="bibr">11</xref>]</sup> The dysregulation of the expression and functionality of vascular cell ion channels constitutes a salient mechanism underlying the pathogenesis and progression of cardiovascular disorders like hypertension, coronary artery disease, and atherosclerosis.<sup>[<xref rid="R12" ref-type="bibr">12</xref>]</sup> Contemporary research indicates that vascular remodeling driven by chronic inflammatory responses resulting from aberrant blood flow is of paramount significance in IA formation, expansion, and rupture.<sup>[<xref rid="R13" ref-type="bibr">13</xref>]</sup> Distinct classes of ion channels within vascular cells are intimately associated with the processes of vascular remodeling and fibrosis.<sup>[<xref rid="R14" ref-type="bibr">14</xref>]</sup> Animal studies have demonstrated alterations in ion channel activity in cerebral arterioles and basilar arteries subsequent to aSAH.<sup>[<xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R16" ref-type="bibr">16</xref>]</sup> Furthermore, in addition to alterations in gene expression associated with voltage-gated calcium channels (VGCCs) following aSAH, vasoactive substances released into the cerebrospinal fluid may also enhance the activity of preexisting VGCCs in the smooth muscle cells of cerebral arteries.<sup>[<xref rid="R17" ref-type="bibr">17</xref>]</sup> Despite the copious evidence suggesting an association between ion channels and aSAH, the majority of investigations remain observational, circumscribed by sample size limitations and confounding variables. A robust correlation exists between variations in ion channel expression and their corresponding genes. Therefore, elucidating the causal relationship between ion channel genes and aSAH may facilitate the unearthing of novel biological mechanisms associated with this condition.</p><p>Mendelian randomization (MR) is a methodological approach employed to infer causal relationships between exposure and outcome.<sup>[<xref rid="R18" ref-type="bibr">18</xref>]</sup> In this study, we integrated expression quantitative trait loci (eQTL) eQTL data for ion channel genes with summary data from genome-wide association studies (GWAS) pertaining to aSAH in order to investigate the causal relationship between ion channel gene expression and the complex traits associated with aSAH. The findings of this study provide novel insights into understanding the interplay between ion channel genes and aSAH while contributing to an enhanced comprehension of its pathogenic mechanisms.</p></sec><sec sec-type="methods"><title>
2. Methods</title><sec><title>
2.1. Study design</title><p>This study utilized eQTL data from 172 ion channel genes and pooled summary data from a GWAS of aSAH to perform a bivariate MR analysis. We selected single nucleotide polymorphisms (SNPs) that exhibited significant associations with exposure factors (<italic toggle="yes">P</italic>-value threshold&#x02005;&#x0003c;&#x02005;5&#x02005;&#x000d7;&#x02005;10<sup>&#x02013;6</sup>) as instrumental variables (IVs), employing inverse variance weighted (IVW) as the primary analytical method. Additionally, sensitivity analyses and heterogeneity tests were conducted to ensure the robustness of our findings. The differentially expressed ion channel genes identified through MR were validated using transcriptomic data, followed by GeneMANIA and functional enrichment assessments, as illustrated in Figure <xref rid="F1" ref-type="fig">1</xref>.</p><fig position="float" id="F1"><label>Figure 1.</label><caption><p>Flowchart of this study. The study design integrates eQTL data, Mendelian randomization, transcriptomic validation, and functional enrichment analysis to investigate the causal role of ion channel genes in aSAH. aSAH = aneurysmal subarachnoid hemorrhage, eQTL = expression quantitative trait loci.</p></caption><graphic xlink:href="medi-104-e42457-g001" position="float"/></fig></sec><sec><title>
2.2. Data sources and extracts</title><p>In this study, 330 ion channel genes were obtained from the Human Genome Organisation Gene Nomenclature Committee (HGNC) database (see Table S1, Supplemental digital content, <ext-link xlink:href="https://links.lww.com/MD/O910" ext-link-type="uri">https://links.lww.com/MD/O910</ext-link> online). The HGNC is jointly funded by the UK Medical Research Council and the US National Institutes of Health, providing a unique identifier for each gene.<sup>[<xref rid="R19" ref-type="bibr">19</xref>]</sup> Utilizing the R package TwoSampleMR, we retrieved GWAS IDs for ion channel genes from the IEU OpenGWAS database. We identified 172 ion channel genes with eQTL present in the GWAS summary data (see Table S2, Supplemental Digital Content, <ext-link xlink:href="https://links.lww.com/MD/O911" ext-link-type="uri">https://links.lww.com/MD/O911</ext-link> online), which served as exposure factors. aSAH was designated as the outcome variable in this analysis. The summary data were derived from the cohort characterized by Bakker, which comprises 23 distinct cohorts of individuals of European ancestry, encompassing a total of 5425 cases of IA rupture and 71,934 control subjects.<sup>[<xref rid="R20" ref-type="bibr">20</xref>]</sup></p><p>Furthermore, transcriptomic data related to aSAH were sourced from GSE13353 within the GEO database, encompassing tissue samples and clinical information from 11 ruptured IAs and 8 unruptured IAs among individuals of European ancestry.<sup>[<xref rid="R21" ref-type="bibr">21</xref>]</sup> These data were utilized for differential expression analysis.</p></sec><sec><title>
2.3. Instrumental variables and data harmonization</title><p>Our study adhered to the 3 fundamental assumptions of MR analysis. Firstly, the SNPs utilized in MR analysis must be closely associated with ion channel genes. Selecting SNPs that are linked to the eQTL of ion channel genes as IVs allows for inferring a direct causal relationship between gene expression and outcomes, thereby facilitating the identification of novel risk genes and pathogenic mechanisms, as well as advancing the development of gene-targeted therapeutic strategies. In this investigation, to ensure an adequate number of IVs were included, we selected SNPs with <italic toggle="yes">P</italic>-value threshold&#x02005;&#x0003c;&#x02005;5&#x02005;&#x000d7;&#x02005;10<sup>&#x02013;6</sup> for analysis. To effectively mitigate bias introduced by weak IVs, we chose IVs with an <italic toggle="yes">F</italic> statistic &#x0003e;10 (formula: <italic toggle="yes">F</italic>&#x02005;=&#x02005;<italic toggle="yes">R</italic><sup>2</sup>(n &#x02212; 2)/(1 &#x02212; <italic toggle="yes">R</italic><sup>2</sup>),<sup>[<xref rid="R22" ref-type="bibr">22</xref>]</sup> where <italic toggle="yes">R</italic><sup>2</sup> denotes the coefficient of determination and n represents the sample size. Secondly, it is essential that the selected IVs satisfy independence criteria. We established a linkage disequilibrium threshold for SNP pairs at <italic toggle="yes">r</italic><sup>2</sup>= 0.001 and kb&#x02005;=&#x02005;10,000 to eliminate potential confounding effects from linkage disequilibrium while maintaining independence among selected IVs. Thirdly, these IVs should not exhibit any association with the outcome variable; thus, we excluded those related to aSAH at <italic toggle="yes">P</italic>-value&#x02005;&#x0003c;&#x02005;.05. During this process, palindromic SNPs were removed through coordinated effects while correcting allelic SNP discrepancies. These selection criteria ensured the robustness and validity of our research findings.</p></sec><sec><title>
2.4. Mendelian randomization analysis</title><p>In this study, we employed 5 methodologies for the 2-sample MR analysis: the IVW method, MR-Egger regression, weighted median estimation, maximum likelihood estimation, and weighted mode analysis. Among these methods, IVW served as the primary analytical approach. All MR analyses were conducted using the 2-Sample MR R package.<sup>[<xref rid="R23" ref-type="bibr">23</xref>]</sup> Within the context of MR-Egger regression, the intercept was utilized to detect pleiotropy; Cochran <italic toggle="yes">Q</italic> statistic (<italic toggle="yes">Q</italic>) and Rucker <italic toggle="yes">Q</italic> statistic (<italic toggle="yes">Q</italic>&#x02019;) were employed to assess heterogeneity in both IVW and MR-Egger estimates.<sup>[<xref rid="R24" ref-type="bibr">24</xref>]</sup> The difference between these 2 <italic toggle="yes">Q</italic>&#x02013;<italic toggle="yes">Q</italic>&#x02019; can be used to evaluate horizontal pleiotropy within the MR estimates. When both the <italic toggle="yes">Q</italic> statistic and its corresponding <italic toggle="yes">P</italic>-value are &#x0003c;.05, it indicates a significant presence of directional pleiotropy.<sup>[<xref rid="R25" ref-type="bibr">25</xref>]</sup> Furthermore, a leave-one-out sensitivity analysis was performed to ascertain the influence of potentially significant SNPs, while Bonferroni correction was applied to adjust for multiple testing.</p></sec><sec><title>
2.5. Expression analysis of candidate ion genes, GeneMANIA and functional enrichment analysis</title><p>In this study, we integrated the GSE13353 dataset and employed the R packages ggpubr and wilcox.test to compare the expression profiles of candidate ion channel genes between ruptured and unruptured IA groups. <italic toggle="yes">P</italic>-value&#x02005;&#x0003c;&#x02005;.05 was considered indicative of significant differential expression between the 2 groups. The genes that were successfully validated are classified as key ion channel genes and will be utilized for subsequent GeneMANIA and functional enrichment analyses.</p></sec></sec><sec sec-type="results"><title>
3. Results</title><sec><title>
3.1. Selection of instrumental variables</title><p>Following the removal of linkage disequilibrium, this study extracted comprehensive SNPs data from the eQTL associated with ion channel genes, including beta coefficients, standard errors, <italic toggle="yes">P</italic>-values, effect alleles, and alternative alleles. Additionally, we calculated the <italic toggle="yes">F</italic> statistic, and all SNPs demonstrated <italic toggle="yes">F</italic>-values&#x0003e;10, indicating the absence of weak IVs in this analysis.</p></sec><sec sec-type="results"><title>
3.2. The results of 2-sample Mendelian randomization</title><p>In this study, ion channel genes were designated as the exposure factors, with aSAH defined as the outcome variable. The MR analysis was conducted using 5 distinct algorithms (see Table S3, Supplementary Digital content, <ext-link xlink:href="https://links.lww.com/MD/O912" ext-link-type="uri">https://links.lww.com/MD/O912</ext-link>). The ion channel genes CACNA2D3 and ANO6 exhibited <italic toggle="yes">P</italic>-values&#x0ff1c;.05, indicating that these 2 genes represent significant genetic risk factors for aSAH. Specifically, 14 single nucleotide SNPs were utilized as IVs for the MR analysis of CACNA2D3, whereas 6 SNPs were employed as IVs for ANO6. The application of the IVW method demonstrated that an increase in CACNA2D3 was significantly positively correlated with an elevated risk of aSAH (OR&#x02005;=&#x02005;1.245; 95% confidence intervals (CI): 1.008&#x02013;1.537; <italic toggle="yes">P</italic>&#x02005;=&#x02005;.042), whereas an increase in ANO6 was significantly negatively correlated with a decreased risk of aSAH (OR&#x02005;=&#x02005;0.728; 95% CI: 0.533&#x02013;0.993; <italic toggle="yes">P</italic>&#x02005;=&#x02005;.045), as illustrated in Figure <xref rid="F2" ref-type="fig">2</xref>. When evaluating the correlation between exposure factors and outcomes, the presence of an intercept indicates that potential confounding factors may be present; however, the IVW analysis revealed that this intercept was minimal, suggesting a limited influence of confounders on the reliability of our findings. Furthermore, the slope associated with CACNA2D3 was positive, indicating its role as a risk factor, whereas ANO6 is considered protective in nature. In terms of randomness assessment, the samples demonstrated an approximately symmetrical distribution on both sides of the IVW line, consistent with Mendel second law of inheritance. Consequently, the estimated diagnostic efficacy at each SNP site further corroborated that CACNA2D3 functions as a risk factor while ANO6 acts as a protective factor against aSAH. Therefore, this study employed 5 MR models to evaluate stable causal associations between CACNA2D3 and ANO6 in relation to aSAH, as illustrated in Figure <xref rid="F3" ref-type="fig">3</xref>.</p><fig position="float" id="F2"><label>Figure 2.</label><caption><p>The forest plot for the MR analysis features. Results of MR analysis for CACNA2D3 and ANO6, showing odds ratios (OR) and 95% CI. CI = confidence intervals, MR = Mendelian randomization.</p></caption><graphic xlink:href="medi-104-e42457-g002" position="float"/></fig><fig position="float" id="F3"><label>Figure 3.</label><caption><p>Mendelian randomization results for ion channel genes and aSAH. (A and B) Scatter plots of genetic associations; (C and D) funnel plots assessing heterogeneity; (E and F) forest plots summarizing effect estimates. aSAH = aneurysmal subarachnoid hemorrhage.</p></caption><graphic xlink:href="medi-104-e42457-g003" position="float"/></fig></sec><sec><title>
3.3. The assessment of heterogeneity and sensitivity in Mendelian randomization</title><p>The results of the heterogeneity test revealed that the Q_pval for CACNA2D3 was &#x0003c;.05, indicating the presence of heterogeneity; conversely, the Q_pval for ANO6 was &#x0003e;.05, suggesting an absence of heterogeneity. (see Table S4, Supplemental Digital Content, <ext-link xlink:href="https://links.lww.com/MD/O913" ext-link-type="uri">https://links.lww.com/MD/O913</ext-link> online). Accordingly, a random-effects IVW model was applied for CACNA2D3 in the MR analysis, whereas a fixed-effects IVW model was employed for ANO6. Both horizontal pleiotropy tests and MR-PRESSO analyses did not reveal any evidence of horizontal pleiotropy (see Table S5, Supplemental Digital Content, <ext-link xlink:href="https://links.lww.com/MD/O914" ext-link-type="uri">https://links.lww.com/MD/O914</ext-link> online). Moreover, &#x0201c;Leave-One-Out&#x0201d; sensitivity and heterogeneity analyses revealed that the exclusion of individual IV did not result in any abnormal findings in the MR analysis related to these ion channel genes and aSAH. Furthermore, no instrumental variable exerted a significant influence on the MR outcomes, as depicted in Figure <xref rid="F4" ref-type="fig">4</xref>. The Steiger direction test was performed to validate the directional causality between exposure and outcome. The directional test <italic toggle="yes">P</italic>-value&#x02005;&#x0003c;&#x02005;.05 suggests that the identified directionality is valid. (see Table S6, Supplemental Digital content, <ext-link xlink:href="https://links.lww.com/MD/O915" ext-link-type="uri">https://links.lww.com/MD/O915</ext-link> online).</p><fig position="float" id="F4"><label>Figure 4.</label><caption><p>Sensitivity analysis of Mendelian randomization. Leave-one-out plots for CACNA2D3 (A) and ANO6 (B) demonstrate the robustness of MR results. MR = Mendelian randomization.</p></caption><graphic xlink:href="medi-104-e42457-g004" position="float"/></fig></sec><sec><title>
3.4. Analysis of the expression profiles of CACNA2D3 and ANO6 in the walls of IA</title><p>A significant difference was observed in the expression levels of the ion channel genes CACNA2D3 and ANO6 between ruptured and unruptured intracranial IA groups (<italic toggle="yes">P</italic>-values &#x0003c; .05). Specifically, CACNA2D3 exhibited elevated expression in the ruptured group, while ANO6 demonstrated higher expression levels in the unruptured group&#x0ff0c;as illustrated in Figure <xref rid="F5" ref-type="fig">5</xref>.</p><fig position="float" id="F5"><label>Figure 5.</label><caption><p>Expression distribution of CACNA2D3 and ANO6 between ruptured and unruptured (IA groups. Violin plots show significant differential expression (Wilcoxon test, <italic toggle="yes">P</italic>&#x02005;&#x0003c;&#x02005;.05). IA = intracranial aneurysm.</p></caption><graphic xlink:href="medi-104-e42457-g005" position="float"/></fig></sec><sec><title>
3.5. GeneMANIA analysis of CACNA2D3 and ANO6</title><p>With respect to CACNA2D3 and ANO6, we identified 20 hub genes associated with these targets. ANO6 is linked to intracellular chloride channel activity, ion-gated channel activity, chloride channel activity, gated channel activity, and anion channel activity; in contrast, CACNA2D3 is primarily associated with gated channel activity. Detailed information can be found in Figure <xref rid="F6" ref-type="fig">6</xref>.</p><fig position="float" id="F6"><label>Figure 6.</label><caption><p>Gene interaction network constructed by GeneMANIA. Functional associations of CACNA2D3 and ANO6 with related ion channel activity pathways.</p></caption><graphic xlink:href="medi-104-e42457-g006" position="float"/></fig></sec><sec><title>
3.6. Gene set enrichment analysis (GSEA) of CACNA2D3 and ANO6</title><p>In the enrichment analyses conducted for Kyoto Encyclopedia of Genes and Genomes, Hallmark, and Reactome, CACNA2D3 was associated with 139, 41, and 496 pathways, respectively. The results of the GSEA indicated that CACNA2D3 is linked to several pathways including influence extracellular matrix (ECM)&#x02013;receptor interaction, transforming growth factor (TGF)-&#x003b2; signaling pathway, oxidative phosphorylation, non-integrin membrane-ECM interactions, and extracellular matrix organization. Additionally, in the aforementioned 3 enrichment methods, gene ANO6 was associated with 140, 41, and 464 pathways, respectively. The GSEA outcomes demonstrate that ANO6 is correlated with pathways such as cytokine-cytokine receptor interactions, TNF&#x003b1;/nuclear factor kappa B, ECM proteoglycans, and integrin cell surface interactions, as illustrated in Figure <xref rid="F7" ref-type="fig">7</xref>.</p><fig position="float" id="F7"><label>Figure 7.</label><caption><p>Pathway enrichment analysis of ANO6 and CACNA2D3. Hallmark, KEGG, and reactome pathways highlight roles in ECM remodeling, immune response, and calcium signaling. ECM = extracellular matrix, KEGG = Kyoto Encyclopedia of Genes and Genomes.</p></caption><graphic xlink:href="medi-104-e42457-g007" position="float"/></fig></sec></sec><sec sec-type="discussion"><title>4. Discussion</title><p>To our knowledge, this study represents the inaugural application of a multi-omics integration approach to identify potential ion channel genes in blood and IA wall tissues, along with elucidating their underlying mechanisms in aSAH. The prevention and management of aSAH pose significant challenges, primarily due to the ambiguous pathophysiological mechanisms associated with the formation and rupture of IA. A causal relationship has been established between the ion channel genes CACNA2D3 and ANO6 and aSAH, wherein increased expression of CACNA2D3 is positively correlated with an elevated risk of aSAH, while heightened levels of ANO6 are inversely associated with a reduced risk. Furthermore, this study substantiates the absence of reverse causality. Additionally, transcriptome data reveal that CACNA2D3 is markedly upregulated in the walls of ruptured IAs, whereas ANO6 exhibits significantly higher expression in unruptured aneurysm walls. Collectively, these findings suggest that alterations in the expression profiles of key risk genes may play a pivotal role in the etiology of aSAH.</p><p>IA is a pathological outward bulging of the intracranial artery, which may be associated with localized thinning of the arterial wall and predisposes it to rupture.<sup>[<xref rid="R26" ref-type="bibr">26</xref>]</sup> The primary mechanisms underlying the formation and progression of IA encompass: endothelial injury and degradation of the elastic layer; recruitment and infiltration of inflammatory cells; and chronic remodeling of the vascular wall.<sup>[<xref rid="R27" ref-type="bibr">27</xref>]</sup> Research has shown that alterations in ion channel configuration within endothelial cells can result in functional impairments.<sup>[<xref rid="R28" ref-type="bibr">28</xref>]</sup> Pathological examinations of human IA walls reveal significant inflammatory infiltration, predominantly characterized by the presence of macrophages and T cells.<sup>[<xref rid="R29" ref-type="bibr">29</xref>,<xref rid="R30" ref-type="bibr">30</xref>]</sup> Ion channels are highly expressed in immune cells and play a critical role in maintaining immune activity, regulating lymphocyte development, and modulating immune responses.<sup>[<xref rid="R31" ref-type="bibr">31</xref>]</sup> Furthermore, the expression levels of different types of ion channels in vascular smooth muscle cells are closely linked to processes associated with vascular remodeling and fibrosis.<sup>[<xref rid="R15" ref-type="bibr">15</xref>]</sup> Consequently, it is evident that ion channels are intricately linked to both the development of IA and aSAH.</p><p>GeneMANIA analysis indicates that CACNA2D3 is closely associated with the regulation of ion channels. VGCCs are multi-subunit protein complexes composed of an &#x003b1;1 subunit and 3 regulatory subunits (&#x003b1;2&#x003b4;, &#x003b2;, and &#x003b3;).<sup>[<xref rid="R32" ref-type="bibr">32</xref>,<xref rid="R33" ref-type="bibr">33</xref>]</sup> CACNA2D3 specifically encodes the &#x003b1;2&#x003b4;3 subunit.<sup>[<xref rid="R34" ref-type="bibr">34</xref>]</sup> Research has demonstrated that as a regulatory subunit, &#x003b1;2&#x003b4;3 facilitates calcium ion translocation across the membrane via VGCCs.<sup>[<xref rid="R35" ref-type="bibr">35</xref>]</sup> During cell membrane depolarization, the opening of VGCCs permits calcium ions to enter cells, thereby influencing cellular excitability, contractility, and other physiological processes. Current studies indicate that mutations, abnormal expression levels, or functional impairments in the CACNA2D3 gene are closely linked to various diseases including neurological disorders,<sup>[<xref rid="R36" ref-type="bibr">36</xref>]</sup> cancers,<sup>[<xref rid="R37" ref-type="bibr">37</xref>]</sup> and type 2 diabetes.<sup>[<xref rid="R38" ref-type="bibr">38</xref>]</sup> Furthermore, GeneMANIA analysis reveals that ANO6 activity primarily involves chloride ion transport through gating mechanisms. ANO6 (also known as TMEM16F) encodes a calcium-dependent chloride channel belonging to the TMEM16 family.<sup>[<xref rid="R39" ref-type="bibr">39</xref>]</sup> The protein product (ANO6 or TMEM16F) promotes chloride efflux and is intricately connected to calcium signaling pathways.<sup>[<xref rid="R40" ref-type="bibr">40</xref>]</sup> Abnormal expression and mutations in the ANO6 gene have been significantly associated with pathogenic mechanisms underlying several diseases such as Scott syndrome,<sup>[<xref rid="R41" ref-type="bibr">41</xref>]</sup> bone formation disorders,<sup>[<xref rid="R42" ref-type="bibr">42</xref>]</sup> and Alzheimer disease.<sup>[<xref rid="R43" ref-type="bibr">43</xref>]</sup> Functional enrichment analysis revealed that pathways associated with CACNA2D3, including cell adhesion receptor interactions, TGF-&#x003b2; signaling pathway, non-integrin membrane-extracellular matrix interactions, and ECM remodeling, emphasize the critical relationships between cells and their microenvironment, which influence tissue architecture, cell migration, and fibrosis among other processes. Conversely, the oxidative phosphorylation pathway encompasses fundamental processes such as energy metabolism, signal transduction, and cellular fate determination. Furthermore, the 4 pathways enriched by ANO6 primarily regulate cellular functions through the modulation of intracellular signaling mechanisms; these pathways are predominantly implicated in immune responses, inflammation, and cell proliferation. This finding carries significant academic implications.</p><p>The pathological examination of the wall of IAs reveals that unruptured aneurysms are characterized by minor structural changes and a reduced number of inflammatory cells, predominantly consisting of M1 macrophages. In contrast, ruptured IAs exhibit significant structural alterations, a marked increase in inflammatory cell populations, and predominance of M2 macrophages.<sup>[<xref rid="R44" ref-type="bibr">44</xref>]</sup> Research demonstrates that M1 macrophages are predominantly characterized by pro-inflammatory properties, whereas M2 macrophages are primarily associated with anti-inflammatory responses and tissue repair mechanisms.<sup>[<xref rid="R45" ref-type="bibr">45</xref>]</sup> The enriched pathways of the CACNA2D3 are linked to M2 macrophages, while the functional enrichment analysis of ANO6 shows a stronger association with M1 macrophages. Therefore, we hypothesize that changes in the expression of CACNA2D3 and ANO6 genes may regulate the polarization of macrophages, thereby affecting the development and rupture of IA, leading to aSAH.</p><p>The upregulation of CACNA2D3 expression facilitates the influx of Ca<sup>2+</sup> into endothelial cells, thereby disrupting their calcium homeostasis and resulting in intracellular calcium overload. This overload triggers mitochondrial dysfunction via the oxidative phosphorylation pathway, subsequently promoting apoptosis in endothelial cells.<sup>[<xref rid="R46" ref-type="bibr">46</xref>]</sup> The apoptosis of endothelial cells induces surrounding active and apoptotic cells to produce TGF-&#x003b2;.<sup>[<xref rid="R47" ref-type="bibr">47</xref>]</sup> Research has demonstrated that endothelial cell apoptosis can initiate monocyte recruitment, myofibroblast differentiation, and accumulation of adjacent tissues. Upon stimulation by TGF-&#x003b2;, monocytes bind this factor to its receptor, activating the downstream Smad signaling pathway. The Smad protein complex then translocates to the nucleus where it regulates the expression of various genes and promotes differentiation towards an M2 phenotype.<sup>[<xref rid="R48" ref-type="bibr">48</xref>]</sup> M2 macrophages ECM&#x02013;receptor interactions as well as ECM-related pathways through the secretion of diverse chemokines and proteases, thus regulating ECM degradation and remodeling processes.<sup>[<xref rid="R49" ref-type="bibr">49</xref>,<xref rid="R50" ref-type="bibr">50</xref>]</sup> Furthermore, M2 macrophages interact with ECM components such as hyaluronic acid by expressing receptors like CD44, which affects their adhesive properties and migratory capabilities.<sup>[<xref rid="R51" ref-type="bibr">51</xref>]</sup> The expression of the ANO6 gene is downregulated in aSAH, whereas validation of group data indicates an upregulation of this gene in unruptured IA. This gene encodes Anoctamin-6, a Ca<sup>2+</sup>-activated ion channel that also exhibits superoxide dismutase activity and facilitates the translocation of phosphatidylserine from the inner to the outer leaflet.<sup>[<xref rid="R52" ref-type="bibr">52</xref>]</sup> The exposure of phosphatidylserine can activate ADAM17 (TNF-&#x003b1; convertase), leading to the release or dissociation of pro-inflammatory mediators such as TNF-&#x003b1; and interleukin-6 (IL-6).<sup>[<xref rid="R53" ref-type="bibr">53</xref>]</sup> Upon binding to its receptor, TNF-&#x003b1; activates the nuclear factor kappa B signaling pathway, which induces the expression of pro-inflammatory cytokines and promotes macrophage polarization towards the M1 phenotype.<sup>[<xref rid="R54" ref-type="bibr">54</xref>]</sup> M1 macrophages are capable of releasing substantial amounts of pro-inflammatory cytokines, thereby exacerbating systemic inflammatory responses. Furthermore, pro-inflammatory mediators like TNF-&#x003b1; and IL-6 can modulate proteoglycan metabolism through ECM-related pathways, playing critical roles in inflammation and tissue remodeling processes.<sup>[<xref rid="R55" ref-type="bibr">55</xref>]</sup> Additionally, TNF-&#x003b1; and IL-6 can initiate integrin-mediated interactions by regulating integrin expression and activation pathways, facilitating recruitment and localization of various immune cell types within the immune system.<sup>[<xref rid="R56" ref-type="bibr">56</xref>]</sup> This presentation elucidates how alterations in the expression of CACNA2D3 and ANO6 genes can drive macrophage differentiation into M1 or M2 phenotypes, while also discussing the potential mechanisms involved in the formation and rupture of IA. Advancements in imaging technology, coupled with an increasingly aging population, have led to a steady rise in the detection rate of asymptomatic unruptured IA, thereby presenting clinicians with a clinical dilemma: whether to pursue preventive treatment or adopt a watchful waiting strategy. This research identifies a novel potential biomarker for high-risk unruptured IA, facilitating early intervention aimed at reducing the incidence of aSAH.</p><p>Several constraints need to be resolved in the present research. Firstly, our research only incorporated 172 ion channel genes and their eQTLs. Future research should incorporate additional ion channel genes, which is essential for a more thorough understanding of the risk factors and underlying mechanisms of aSAH. Secondly, MR analyses can ascertain whether the observed correlations have causal relationships based on genetic evidence, which is regarded as a causal assumption. To establish the precise causal relationship between ion channel genes and aSAH, further laboratory and clinical investigations are typically required to uncover the potential biological mechanisms. While our study examined the mechanisms underlying the causal relationship between ion channel genes and aSAH, additional clinical trials and mechanistic investigations are necessary for confirmation. Thirdly, the transcriptomic validation cohort included 11 ruptured and 8 unruptured aneurysms, which may limit the generalizability of our findings. While the differential expression of CACNA2D3 and ANO6 was statistically significant, larger cohorts are needed to confirm these results and reduce potential biases inherent to small sample sizes.</p><p>In summary, our research offers MR evidence that supports the causal involvement of the ion channel genes CACNA2D3 and ANO6 in aSAH. We aim to achieve a deeper understanding of the mechanisms of the complex disease aSAH and to identify potential risk factors.</p></sec><sec><title>Acknowledgments</title><p>The author would like to express his sincere gratitude to GEO database and GWAS database for sharing their data.</p></sec><sec><title>Author contributions</title><p><bold>Conceptualization:</bold> Jing Wang, Bowang Chen, Zhen Ma.</p><p><bold>Data curation:</bold> Jing Wang, Bowang Chen, Zhen Ma.</p><p><bold>Formal analysis:</bold> Jing Wang, Bowang Chen, Feng Qu, Zhen Ma.</p><p><bold>Funding acquisition:</bold> Jing Wang, Feng Qu, Zhen Ma.</p><p><bold>Investigation:</bold> Bowang Chen, Feng Qu, Zhen Ma.</p><p><bold>Methodology:</bold> Qiang Meng, Zhen Ma.</p><p><bold>Project administration:</bold> Jing Wang, Bowang Chen, Qiang Meng, Feng Qu, Zhen Ma.</p><p><bold>Resources:</bold> Jing Wang, Bowang Chen, Qiang Meng, Feng Qu, Zhen Ma.</p><p><bold>Software:</bold> Bowang Chen, Qiang Meng, Zhen Ma.</p><p><bold>Supervision:</bold> Jing Wang, Bowang Chen, Qiang Meng, Zhen Ma.</p><p><bold>Validation:</bold> Qiang Meng, Zhen Ma.</p><p><bold>Visualization:</bold> Qiang Meng, Zhen Ma.</p><p><bold>Writing &#x02013; original draft:</bold> Jing Wang, Bowang Chen, Zhen Ma.</p><p><bold>Writing &#x02013; review &#x00026; editing:</bold> Jing Wang, Zhen Ma.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><fig id="s001" position="anchor"><media xlink:href="medi-104-e42457-s001.docx"/></fig><fig id="s002" position="anchor"><media xlink:href="medi-104-e42457-s002.docx"/></fig><fig id="s003" position="anchor"><media xlink:href="medi-104-e42457-s003.docx"/></fig><fig id="s004" position="anchor"><media xlink:href="medi-104-e42457-s004.docx"/></fig><fig id="s005" position="anchor"><media xlink:href="medi-104-e42457-s005.docx"/></fig><fig id="s006" position="anchor"><media xlink:href="medi-104-e42457-s006.docx"/></fig></sec></body><back><fn-group><fn fn-type="abbr"><p>
<def-list><title>Abbreviations:</title><def-item><term>aSAH</term><def><p>aneurysmal subarachnoid hemorrhage</p></def></def-item><def-item><term>ECM</term><def><p>influence extracellular matrix</p></def></def-item><def-item><term>eQTL</term><def><p>expression quantitative trait loci</p></def></def-item><def-item><term>GWAS</term><def><p>genome-wide association studies</p></def></def-item><def-item><term>HGNC</term><def><p>HUGO Gene Nomenclature Committee</p></def></def-item><def-item id="kfd44"><term>HUGO</term><def><p>Human Genome Organisation</p></def></def-item><def-item><term>IA</term><def><p>intracranial aneurysm</p></def></def-item><def-item><term>IVW</term><def><p>inverse variance weighted</p></def></def-item><def-item><term>MR</term><def><p>Mendelian randomization</p></def></def-item><def-item><term>SNPs</term><def><p>single nucleotide polymorphisms</p></def></def-item><def-item><term>TGF</term><def><p>transforming growth factor</p></def></def-item><def-item><term>VGCCs</term><def><p>voltage-gated calcium channels</p></def></def-item></def-list>
</p></fn></fn-group><fn-group><fn fn-type="other"><p>Ethical approval for the GWAS and transcriptomic datasets was obtained by the original studies, and all data were de-identified. This secondary analysis of publicly available data was exempt from additional ethical review per institutional guidelines.</p></fn><fn fn-type="COI-statement"><p>The authors have no funding and conflicts of interest to disclose.</p></fn><fn fn-type="other"><p>The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.</p></fn><fn fn-type="supplementary-material"><p>Supplemental Digital Content is available for this article.</p></fn><fn fn-type="other"><p>How to cite this article: Wang J, Chen B, Meng Q, Qu F, Ma Z. Using eQTL Mendelian randomization and transcriptomic analysis to identify the relationship between ion channel genes and intracranial aneurysmal subarachnoid hemorrhage. Medicine 2025;104:20(e42457).</p></fn><fn fn-type="equal"><p>JW and BC contributed to this article equally.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>[1]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vlak</surname><given-names>MH</given-names></name><name><surname>Algra</surname><given-names>A</given-names></name><name><surname>Brandenburg</surname><given-names>R</given-names></name><name><surname>Rinkel</surname><given-names>GJ</given-names></name></person-group>. <article-title>Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis.</article-title>
<source>Lancet Neurol</source>. <year>2011</year>;<volume>10</volume>:<fpage>626</fpage>&#x02013;<lpage>36</lpage>.<pub-id pub-id-type="pmid">21641282</pub-id>
</mixed-citation></ref><ref id="R2"><label>[2]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macdonald</surname><given-names>RL</given-names></name><name><surname>Schweizer</surname><given-names>TA</given-names></name></person-group>. <article-title>Spontaneous subarachnoid haemorrhage.</article-title>
<source>Lancet</source>. <year>2017</year>;<volume>389</volume>:<fpage>655</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="pmid">27637674</pub-id>
</mixed-citation></ref><ref id="R3"><label>[3]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Etminan</surname><given-names>N</given-names></name><name><surname>Chang</surname><given-names>H-S</given-names></name><name><surname>Hackenberg</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Worldwide incidence of aneurysmal subarachnoid hemorrhage according to region, time period, blood pressure, and smoking prevalence in the population: a systematic review and meta-analysis.</article-title>
<source>JAMA Neurol</source>. <year>2019</year>;<volume>76</volume>:<fpage>588</fpage>&#x02013;<lpage>97</lpage>.<pub-id pub-id-type="pmid">30659573</pub-id>
</mixed-citation></ref><ref id="R4"><label>[4]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>A</given-names></name><name><surname>Yu</surname><given-names>Q</given-names></name><etal/></person-group>. <article-title>Single-cell RNA sequencing and spatial transcriptomics reveal pathogenesis of meningeal lymphatic dysfunction after experimental subarachnoid hemorrhage.</article-title>
<source>Adv Sci</source>. <year>2023</year>;<volume>10</volume>:<fpage>2301428</fpage>.</mixed-citation></ref><ref id="R5"><label>[5]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicholson</surname><given-names>P</given-names></name><name><surname>O&#x02019;Hare</surname><given-names>A</given-names></name><name><surname>Power</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Decreasing incidence of subarachnoid hemorrhage.</article-title>
<source>J Neurointerv Surg</source>. <year>2019</year>;<volume>11</volume>:<fpage>320</fpage>&#x02013;<lpage>2</lpage>.<pub-id pub-id-type="pmid">30314993</pub-id>
</mixed-citation></ref><ref id="R6"><label>[6]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romoli</surname><given-names>M</given-names></name><name><surname>Giammello</surname><given-names>F</given-names></name><name><surname>Mosconi</surname><given-names>MG</given-names></name><etal/></person-group>; <collab>IAY (Italian Stroke Association &#x02013; Young Section)</collab>. <article-title>Immunological profile of vasospasm after subarachnoid hemorrhage.</article-title>
<source>Int J Mol Sci</source> . <year>2023</year>;<volume>24</volume>:<fpage>8856</fpage>.<pub-id pub-id-type="pmid">37240207</pub-id>
</mixed-citation></ref><ref id="R7"><label>[7]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramirez</surname><given-names>GA</given-names></name><name><surname>Coletto</surname><given-names>LA</given-names></name><name><surname>Sciorati</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Ion channels and transporters in inflammation: special focus on TRP channels and TRPC6.</article-title>
<source>Cells</source>. <year>2018</year>;<volume>7</volume>:<fpage>70</fpage>.<pub-id pub-id-type="pmid">29973568</pub-id>
</mixed-citation></ref><ref id="R8"><label>[8]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>House</surname><given-names>SJ</given-names></name><name><surname>Potier</surname><given-names>M</given-names></name><name><surname>Bisaillon</surname><given-names>J</given-names></name><name><surname>Singer</surname><given-names>HA</given-names></name><name><surname>Trebak</surname><given-names>M</given-names></name></person-group>. <article-title>The non-excitable smooth muscle: calcium signaling and phenotypic switching during vascular disease.</article-title>
<source>Pflugers Archiv</source>. <year>2008</year>;<volume>456</volume>:<fpage>769</fpage>&#x02013;<lpage>85</lpage>.<pub-id pub-id-type="pmid">18365243</pub-id>
</mixed-citation></ref><ref id="R9"><label>[9]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Xu</surname><given-names>Q</given-names></name></person-group>. <article-title>Mechanical stress-initiated signal transductions in vascular smooth muscle cells.</article-title>
<source>Cell Signal</source>. <year>2000</year>;<volume>12</volume>:<fpage>435</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="pmid">10989277</pub-id>
</mixed-citation></ref><ref id="R10"><label>[10]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stauderman</surname><given-names>KA</given-names></name></person-group>. <article-title>CRAC channels as targets for drug discovery and development.</article-title>
<source>Cell Calcium</source>. <year>2018</year>;<volume>74</volume>:<fpage>147</fpage>&#x02013;<lpage>59</lpage>.<pub-id pub-id-type="pmid">30075400</pub-id>
</mixed-citation></ref><ref id="R11"><label>[11]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pangrsic</surname><given-names>T</given-names></name><name><surname>Singer</surname><given-names>JH</given-names></name><name><surname>Koschak</surname><given-names>A</given-names></name></person-group>. <article-title>Voltage-gated calcium channels: key players in sensory coding in the retina and the inner ear.</article-title>
<source>Physiol Rev</source>. <year>2018</year>;<volume>98</volume>:<fpage>2063</fpage>&#x02013;<lpage>96</lpage>.<pub-id pub-id-type="pmid">30067155</pub-id>
</mixed-citation></ref><ref id="R12"><label>[12]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>J</given-names></name><name><surname>Wen</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Xu</surname><given-names>Q</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name></person-group>. <article-title>Ion channels and vascular diseases.</article-title>
<source>Arterioscler Thromb Vasc Biol</source>. <year>2019</year>;<volume>39</volume>:<fpage>e146</fpage>&#x02013;<lpage>56</lpage>.<pub-id pub-id-type="pmid">31017824</pub-id>
</mixed-citation></ref><ref id="R13"><label>[13]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fr&#x000f6;sen</surname><given-names>J</given-names></name><name><surname>Cebral</surname><given-names>J</given-names></name><name><surname>Robertson</surname><given-names>AM</given-names></name><name><surname>Aoki</surname><given-names>T</given-names></name></person-group>. <article-title>Flow-induced, inflammation-mediated arterial wall remodeling in the formation and progression of intracranial aneurysms.</article-title>
<source>Neurosurg Focus</source>. <year>2019</year>;<volume>47</volume>:<fpage>E21</fpage>.</mixed-citation></ref><ref id="R14"><label>[14]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Tian</surname><given-names>H</given-names></name><name><surname>Xie</surname><given-names>C</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Cheng</surname><given-names>J</given-names></name></person-group>. <article-title>The role and mechanism of vascularwall cell ion channels in vascular fibrosis remodeling.</article-title>
<source>Channels</source>. <year>2024</year>;<volume>18</volume>:<fpage>2418128</fpage>.<pub-id pub-id-type="pmid">39425532</pub-id>
</mixed-citation></ref><ref id="R15"><label>[15]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishiguro</surname><given-names>M</given-names></name><name><surname>Wellman</surname><given-names>TL</given-names></name><name><surname>Honda</surname><given-names>A</given-names></name><name><surname>Russell</surname><given-names>SR</given-names></name><name><surname>Tranmer</surname><given-names>BI</given-names></name><name><surname>Wellman</surname><given-names>GC</given-names></name></person-group>. <article-title>Emergence of a R-type Ca2+ channel (CaV 2.3) contributes to cerebral artery constriction after subarachnoid hemorrhage.</article-title>
<source>Circ Res</source>. <year>2005</year>;<volume>96</volume>:<fpage>419</fpage>&#x02013;<lpage>26</lpage>.<pub-id pub-id-type="pmid">15692089</pub-id>
</mixed-citation></ref><ref id="R16"><label>[16]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikitina</surname><given-names>E</given-names></name><name><surname>Kawashima</surname><given-names>A</given-names></name><name><surname>Takahashi</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Alteration in voltage-dependent calcium channels in dog basilar artery after subarachnoid hemorrhage.</article-title>
<source>J Neurosurg</source>. <year>2010</year>;<volume>113</volume>:<fpage>870</fpage>&#x02013;<lpage>80</lpage>.<pub-id pub-id-type="pmid">20225918</pub-id>
</mixed-citation></ref><ref id="R17"><label>[17]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wellman</surname><given-names>GC</given-names></name></person-group>. <article-title>Ion channels and calcium signaling in cerebral arteries following subarachnoid hemorrhage.</article-title>
<source>Neurol Res</source>. <year>2006</year>;<volume>28</volume>:<fpage>690</fpage>&#x02013;<lpage>702</lpage>.<pub-id pub-id-type="pmid">17164032</pub-id>
</mixed-citation></ref><ref id="R18"><label>[18]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davey Smith</surname><given-names>G</given-names></name><name><surname>Hemani</surname><given-names>G</given-names></name></person-group>. <article-title>Mendelian randomization: genetic anchors for causal inference in epidemiological studies.</article-title>
<source>Hum Mol Genet</source>. <year>2014</year>;<volume>23</volume>:<fpage>R89</fpage>&#x02013;<lpage>98</lpage>.<pub-id pub-id-type="pmid">25064373</pub-id>
</mixed-citation></ref><ref id="R19"><label>[19]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Povey</surname><given-names>S</given-names></name><name><surname>Lovering</surname><given-names>R</given-names></name><name><surname>Bruford</surname><given-names>E</given-names></name><name><surname>Wright</surname><given-names>M</given-names></name><name><surname>Lush</surname><given-names>M</given-names></name><name><surname>Wain</surname><given-names>H</given-names></name></person-group>. <article-title>The HUGO gene nomenclature committee (HGNC).</article-title>
<source>Hum Genet</source>. <year>2001</year>;<volume>109</volume>:<fpage>678</fpage>&#x02013;<lpage>80</lpage>.<pub-id pub-id-type="pmid">11810281</pub-id>
</mixed-citation></ref><ref id="R20"><label>[20]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakker</surname><given-names>MK</given-names></name><name><surname>van der Spek</surname><given-names>RA</given-names></name><name><surname>van Rheenen</surname><given-names>W</given-names></name><etal/></person-group>. <article-title>Genome-wide association study of intracranial aneurysms identifies 17 risk loci and genetic overlap with clinical risk factors.</article-title>
<source>Nat Genet</source>. <year>2020</year>;<volume>52</volume>:<fpage>1303</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="pmid">33199917</pub-id>
</mixed-citation></ref><ref id="R21"><label>[21]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurki</surname><given-names>MI</given-names></name><name><surname>H&#x000e4;kkinen</surname><given-names>S-K</given-names></name><name><surname>Fr&#x000f6;sen</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Upregulated signaling pathways in ruptured human saccular intracranial aneurysm wall: an emerging regulative role of Toll-like receptor signaling and nuclear factor-&#x003ba;B, hypoxia-inducible factor-1A, and ETS transcription factors.</article-title>
<source>Neurosurgery</source>. <year>2011</year>;<volume>68</volume>:<fpage>1667</fpage>&#x02013;<lpage>75; discussion 1675</lpage>.<pub-id pub-id-type="pmid">21336216</pub-id>
</mixed-citation></ref><ref id="R22"><label>[22]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Lian</surname><given-names>Q</given-names></name><name><surname>Nie</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name></person-group>. <article-title>Causal relationship between serum uric acid and cardiovascular disease: a Mendelian randomization study.</article-title>
<source>IJC Heart Vasculature</source>. <year>2024</year>;<volume>54</volume>:<fpage>101453</fpage>.<pub-id pub-id-type="pmid">39411145</pub-id>
</mixed-citation></ref><ref id="R23"><label>[23]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hemani</surname><given-names>G</given-names></name><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>Elsworth</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>The MR-Base platform supports systematic causal inference across the human phenome.</article-title>
<source>elife</source>. <year>2018</year>;<volume>7</volume>:<fpage>e34408</fpage>.<pub-id pub-id-type="pmid">29846171</pub-id>
</mixed-citation></ref><ref id="R24"><label>[24]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egger</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>GD</given-names></name><name><surname>Schneider</surname><given-names>M</given-names></name><name><surname>Minder</surname><given-names>C</given-names></name></person-group>. <article-title>Bias in meta-analysis detected by a simple, graphical test.</article-title>
<source>BMJ</source>. <year>1997</year>;<volume>315</volume>:<fpage>629</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="pmid">9310563</pub-id>
</mixed-citation></ref><ref id="R25"><label>[25]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>R&#x000fc;cker</surname><given-names>G</given-names></name><name><surname>Schwarzer</surname><given-names>G</given-names></name><name><surname>Carpenter</surname><given-names>JR</given-names></name><name><surname>Binder</surname><given-names>H</given-names></name><name><surname>Schumacher</surname><given-names>M</given-names></name></person-group>. <article-title>Treatment-effect estimates adjusted for small-study effects via a limit meta-analysis.</article-title>
<source>Biostatistics</source>. <year>2011</year>;<volume>12</volume>:<fpage>122</fpage>&#x02013;<lpage>42</lpage>.<pub-id pub-id-type="pmid">20656692</pub-id>
</mixed-citation></ref><ref id="R26"><label>[26]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiebers</surname><given-names>DO</given-names></name><name><surname>Piepgras</surname><given-names>DG</given-names></name><name><surname>Meyer</surname><given-names>FB</given-names></name></person-group>, <etal/>. <article-title>Pathogenesis, natural history, and treatment of unruptured intracranial aneurysms.</article-title>
<source>Mayo Clin Proc</source>. <year>2004</year>;<volume>79</volume>:<fpage>1572</fpage>&#x02013;<lpage>83</lpage>.<pub-id pub-id-type="pmid">15595346</pub-id>
</mixed-citation></ref><ref id="R27"><label>[27]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hosaka</surname><given-names>K</given-names></name><name><surname>Hoh</surname><given-names>BL</given-names></name></person-group>. <article-title>Inflammation and cerebral aneurysms.</article-title>
<source>Transl stroke Res</source>. <year>2014</year>;<volume>5</volume>:<fpage>190</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">24323732</pub-id>
</mixed-citation></ref><ref id="R28"><label>[28]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos-Gomes</surname><given-names>J</given-names></name><name><surname>Le Ribeuz</surname><given-names>H</given-names></name><name><surname>Br&#x000e1;s-Silva</surname><given-names>C</given-names></name><name><surname>Antigny</surname><given-names>F</given-names></name><name><surname>Ad&#x000e3;o</surname><given-names>R</given-names></name></person-group>. <article-title>Role of ion channel remodeling in endothelial dysfunction induced by pulmonary arterial hypertension.</article-title>
<source>Biomolecules</source>. <year>2022</year>;<volume>12</volume>:<fpage>484</fpage>.<pub-id pub-id-type="pmid">35454073</pub-id>
</mixed-citation></ref><ref id="R29"><label>[29]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fr&#x000f6;sen</surname><given-names>J</given-names></name><name><surname>Piippo</surname><given-names>A</given-names></name><name><surname>Paetau</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Growth factor receptor expression and remodeling of saccular cerebral artery aneurysm walls: implications for biological therapy preventing rupture.</article-title>
<source>Neurosurgery</source>. <year>2006</year>;<volume>58</volume>:<fpage>534</fpage>&#x02013;<lpage>41; discussion 534</lpage>.<pub-id pub-id-type="pmid">16528195</pub-id>
</mixed-citation></ref><ref id="R30"><label>[30]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aoki</surname><given-names>T</given-names></name><name><surname>Kataoka</surname><given-names>H</given-names></name><name><surname>Morimoto</surname><given-names>M</given-names></name><name><surname>Nozaki</surname><given-names>K</given-names></name><name><surname>Hashimoto</surname><given-names>N</given-names></name></person-group>. <article-title>Macrophage-derived matrix metalloproteinase-2 and-9 promote the progression of cerebral aneurysms in rats.</article-title>
<source>Stroke</source>. <year>2007</year>;<volume>38</volume>:<fpage>162</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">17122420</pub-id>
</mixed-citation></ref><ref id="R31"><label>[31]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title>The role of ion channels in immune-related diseases.</article-title>
<source>Prog Biophys Mol Biol</source>. <year>2023</year>;<volume>177</volume>:<fpage>129</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="pmid">36417963</pub-id>
</mixed-citation></ref><ref id="R32"><label>[32]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>A</given-names></name><name><surname>Hendrich</surname><given-names>J</given-names></name><name><surname>Van Minh</surname><given-names>AT</given-names></name><name><surname>Wratten</surname><given-names>J</given-names></name><name><surname>Douglas</surname><given-names>L</given-names></name><name><surname>Dolphin</surname><given-names>AC</given-names></name></person-group>. <article-title>Functional biology of the &#x003b1;2&#x003b4; subunits of voltage-gated calcium channels.</article-title>
<source>Trends Pharmacol Sci</source>. <year>2007</year>;<volume>28</volume>:<fpage>220</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">17403543</pub-id>
</mixed-citation></ref><ref id="R33"><label>[33]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>H</given-names></name><name><surname>Hang</surname><given-names>J</given-names></name><name><surname>Kohler</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Su</surname><given-names>T-Z</given-names></name></person-group>. <article-title>Tissue-specific expression and gabapentin- binding properties of calcium channel &#x003b1;2&#x003b4; subunit subtypes.</article-title>
<source>J Membr Biol</source>. <year>2001</year>;<volume>184</volume>:<fpage>35</fpage>&#x02013;<lpage>43</lpage>.<pub-id pub-id-type="pmid">11687876</pub-id>
</mixed-citation></ref><ref id="R34"><label>[34]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>N</given-names></name><name><surname>Yagel</surname><given-names>S</given-names></name><name><surname>Momplaisir</surname><given-names>M-L</given-names></name><name><surname>Codd</surname><given-names>EE</given-names></name><name><surname>D&#x02019;Andrea</surname><given-names>MR</given-names></name></person-group>. <article-title>Molecular cloning and characterization of the human voltage-gated calcium channel &#x003b1;2&#x003b4;-4 subunit.</article-title>
<source>Mol Pharmacol</source>. <year>2002</year>;<volume>62</volume>:<fpage>485</fpage>&#x02013;<lpage>96</lpage>.<pub-id pub-id-type="pmid">12181424</pub-id>
</mixed-citation></ref><ref id="R35"><label>[35]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>A</given-names></name><name><surname>Kadurin</surname><given-names>I</given-names></name><name><surname>Alvarez-Laviada</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>The &#x003b1;2&#x003b4; subunits of voltage-gated calcium channels form GPI-anchored proteins, a posttranslational modification essential for function.</article-title>
<source>Proc Natl Acad Sci USA</source>. <year>2010</year>;<volume>107</volume>:<fpage>1654</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">20080692</pub-id>
</mixed-citation></ref><ref id="R36"><label>[36]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villela</surname><given-names>D</given-names></name><name><surname>Suemoto</surname><given-names>CK</given-names></name><name><surname>Pasqualucci</surname><given-names>CA</given-names></name><name><surname>Grinberg</surname><given-names>LT</given-names></name><name><surname>Rosenberg</surname><given-names>C</given-names></name></person-group>. <article-title>Do copy number changes in CACNA2D2, CACNA2D3, and CACNA1D constitute a predisposing risk factor for Alzheimer&#x02019;s disease?</article-title>
<source>Front Genet</source>. <year>2016</year>;<volume>7</volume>:<fpage>107</fpage>.<pub-id pub-id-type="pmid">27379157</pub-id>
</mixed-citation></ref><ref id="R37"><label>[37]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nie</surname><given-names>C</given-names></name><name><surname>Qin</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>CACNA2D3 enhances the chemosensitivity of esophageal squamous cell carcinoma to cisplatin via inducing Ca2+-mediated apoptosis and suppressing PI3K/Akt pathways.</article-title>
<source>Front Oncol</source>. <year>2019</year>;<volume>9</volume>:<fpage>185</fpage>.<pub-id pub-id-type="pmid">31001468</pub-id>
</mixed-citation></ref><ref id="R38"><label>[38]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>RB</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Rosselot</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Single-nucleus RNA sequencing of human pancreatic islets identifies novel gene sets and distinguishes &#x003b2;-cell subpopulations with dynamic transcriptome profiles.</article-title>
<source>Genome Med</source>. <year>2023</year>;<volume>15</volume>:<fpage>30</fpage>.<pub-id pub-id-type="pmid">37127706</pub-id>
</mixed-citation></ref><ref id="R39"><label>[39]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martins</surname><given-names>JR</given-names></name><name><surname>Faria</surname><given-names>D</given-names></name><name><surname>Kongsuphol</surname><given-names>P</given-names></name><name><surname>Reisch</surname><given-names>B</given-names></name><name><surname>Schreiber</surname><given-names>R</given-names></name><name><surname>Kunzelmann</surname><given-names>K</given-names></name></person-group>. <article-title>Anoctamin 6 is an essential component of the outwardly rectifying chloride channel.</article-title>
<source>Proc Natl Acad Sci USA</source>. <year>2011</year>;<volume>108</volume>:<fpage>18168</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="pmid">22006324</pub-id>
</mixed-citation></ref><ref id="R40"><label>[40]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimizu</surname><given-names>T</given-names></name><name><surname>Iehara</surname><given-names>T</given-names></name><name><surname>Sato</surname><given-names>K</given-names></name><name><surname>Fujii</surname><given-names>T</given-names></name><name><surname>Sakai</surname><given-names>H</given-names></name><name><surname>Okada</surname><given-names>Y</given-names></name></person-group>. <article-title>TMEM16F is a component of a Ca2+-activated Cl&#x02212; channel but not a volume-sensitive outwardly rectifying Cl&#x02212; channel.</article-title>
<source>Am J Physiol Cell Physiol</source>. <year>2013</year>;<volume>304</volume>:<fpage>C748</fpage>&#x02013;<lpage>59</lpage>.<pub-id pub-id-type="pmid">23426967</pub-id>
</mixed-citation></ref><ref id="R41"><label>[41]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>J</given-names></name><name><surname>Umeda</surname><given-names>M</given-names></name><name><surname>Sims</surname><given-names>PJ</given-names></name><name><surname>Nagata</surname><given-names>S</given-names></name></person-group>. <article-title>Calcium-dependent phospholipid scrambling by TMEM16F.</article-title>
<source>Nature</source>. <year>2010</year>;<volume>468</volume>:<fpage>834</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">21107324</pub-id>
</mixed-citation></ref><ref id="R42"><label>[42]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehlen</surname><given-names>HW</given-names></name><name><surname>Chinenkova</surname><given-names>M</given-names></name><name><surname>Moser</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Inactivation of anoctamin-6/Tmem16f, a regulator of phosphatidylserine scrambling in osteoblasts, leads to decreased mineral deposition in skeletal tissues.</article-title>
<source>J Bone Miner Res</source>. <year>2013</year>;<volume>28</volume>:<fpage>246</fpage>&#x02013;<lpage>59</lpage>.<pub-id pub-id-type="pmid">22936354</pub-id>
</mixed-citation></ref><ref id="R43"><label>[43]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>Z-Q</given-names></name><name><surname>Hu</surname><given-names>X-Y</given-names></name><name><surname>Yang</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>TMEM16F may be a new therapeutic target for Alzheimer&#x02019;s disease.</article-title>
<source>Neural Regener Res</source>. <year>2023</year>;<volume>18</volume>:<fpage>643</fpage>&#x02013;<lpage>51</lpage>.</mixed-citation></ref><ref id="R44"><label>[44]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stratilov&#x000e1;</surname><given-names>MH</given-names></name><name><surname>Kobl&#x000ed;&#x0017e;ek</surname><given-names>M</given-names></name><name><surname>&#x00160;tekl&#x000e1;&#x0010d;ov&#x000e1;</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Increased macrophage M2/M1 ratio is associated with intracranial aneurysm rupture.</article-title>
<source>Acta Neurochir</source>. <year>2023</year>;<volume>165</volume>:<fpage>177</fpage>&#x02013;<lpage>86</lpage>.<pub-id pub-id-type="pmid">36437400</pub-id>
</mixed-citation></ref><ref id="R45"><label>[45]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>X-H</given-names></name><name><surname>Jin</surname><given-names>L</given-names></name></person-group>. <article-title>Macrophage polarization in physiological and pathological pregnancy.</article-title>
<source>Front Immunol</source>. <year>2019</year>;<volume>10</volume>:<fpage>792</fpage>.<pub-id pub-id-type="pmid">31037072</pub-id>
</mixed-citation></ref><ref id="R46"><label>[46]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanwar</surname><given-names>J</given-names></name><name><surname>Singh</surname><given-names>JB</given-names></name><name><surname>Motiani</surname><given-names>RK</given-names></name></person-group>. <article-title>Molecular machinery regulating mitochondrial calcium levels: the nuts and bolts of mitochondrial calcium dynamics.</article-title>
<source>Mitochondrion</source>. <year>2021</year>;<volume>57</volume>:<fpage>9</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="pmid">33316420</pub-id>
</mixed-citation></ref><ref id="R47"><label>[47]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Xiong</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>Endothelial cell apoptosis induces TGF-&#x003b2; signaling-dependent host endothelial&#x02013;mesenchymal transition to promote transplant arteriosclerosis.</article-title>
<source>Am J Transplant</source>. <year>2015</year>;<volume>15</volume>:<fpage>3095</fpage>&#x02013;<lpage>111</lpage>.<pub-id pub-id-type="pmid">26372910</pub-id>
</mixed-citation></ref><ref id="R48"><label>[48]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>N</given-names></name><name><surname>Liang</surname><given-names>H</given-names></name><name><surname>Zen</surname><given-names>K</given-names></name></person-group>. <article-title>Molecular mechanisms that influence the macrophage M1&#x02013;M2 polarization balance.</article-title>
<source>Front Immunol</source>. <year>2014</year>;<volume>5</volume>:<fpage>614</fpage>.<pub-id pub-id-type="pmid">25506346</pub-id>
</mixed-citation></ref><ref id="R49"><label>[49]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wynn</surname><given-names>TA</given-names></name><name><surname>Vannella</surname><given-names>KM</given-names></name></person-group>. <article-title>Macrophages in tissue repair, regeneration, and fibrosis.</article-title>
<source>Immunity</source>. <year>2016</year>;<volume>44</volume>:<fpage>450</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="pmid">26982353</pub-id>
</mixed-citation></ref><ref id="R50"><label>[50]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wynn</surname><given-names>T</given-names></name></person-group>. <article-title>Cellular and molecular mechanisms of fibrosis.</article-title>
<source>J Pathol</source>. <year>2008</year>;<volume>214</volume>:<fpage>199</fpage>&#x02013;<lpage>210</lpage>.<pub-id pub-id-type="pmid">18161745</pub-id>
</mixed-citation></ref><ref id="R51"><label>[51]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>D</given-names></name><name><surname>Liang</surname><given-names>J</given-names></name><name><surname>Noble</surname><given-names>PW</given-names></name></person-group>. <article-title>Hyaluronan as an immune regulator in human diseases.</article-title>
<source>Physiol Rev</source>. <year>2011</year>;<volume>91</volume>:<fpage>221</fpage>&#x02013;<lpage>64</lpage>.<pub-id pub-id-type="pmid">21248167</pub-id>
</mixed-citation></ref><ref id="R52"><label>[52]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bleibaum</surname><given-names>F</given-names></name><name><surname>Sommer</surname><given-names>A</given-names></name><name><surname>Veit</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>ADAM10 sheddase activation is controlled by cell membrane asymmetry.</article-title>
<source>J Mol Cell Biol</source>. <year>2019</year>;<volume>11</volume>:<fpage>979</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="pmid">30753537</pub-id>
</mixed-citation></ref><ref id="R53"><label>[53]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arga&#x000f1;araz</surname><given-names>GA</given-names></name><name><surname>Palmeira</surname><given-names>JF</given-names></name><name><surname>Arga&#x000f1;araz</surname><given-names>ER</given-names></name></person-group>. <article-title>Phosphatidylserine inside out: a possible underlying mechanism in the inflammation and coagulation abnormalities of COVID-19.</article-title>
<source>Cell Commun Signal</source>. <year>2020</year>;<volume>18</volume>:<fpage>190</fpage>.<pub-id pub-id-type="pmid">33357215</pub-id>
</mixed-citation></ref><ref id="R54"><label>[54]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>J-s</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Substrate-specific recognition of IKKs mediated by USP16 facilitates autoimmune inflammation.</article-title>
<source>Sci Adv</source>. <year>2021</year>;<volume>7</volume>:<fpage>eabc4009</fpage>.<pub-id pub-id-type="pmid">33523871</pub-id>
</mixed-citation></ref><ref id="R55"><label>[55]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Yan</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Inflammation and tumor progression: signaling pathways and targeted intervention.</article-title>
<source>Signal Transduct Target Ther</source>. <year>2021</year>;<volume>6</volume>:<fpage>263</fpage>.<pub-id pub-id-type="pmid">34248142</pub-id>
</mixed-citation></ref><ref id="R56"><label>[56]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McInnes</surname><given-names>IB</given-names></name><name><surname>Schett</surname><given-names>G</given-names></name></person-group>. <article-title>The pathogenesis of rheumatoid arthritis.</article-title>
<source>N Engl J Med</source>. <year>2011</year>;<volume>365</volume>:<fpage>2205</fpage>&#x02013;<lpage>19</lpage>.<pub-id pub-id-type="pmid">22150039</pub-id>
</mixed-citation></ref></ref-list></back></article>